Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
With appropriate formulation strategies, including the use of absorption enhancers and protective carriers, intranasal GLP-1 therapies could offer a noninvasive, patient-friendly alternative to injections
According to the Centers for Disease Control (CDC), roughly 2% of the population, or about 6.5 million people, suffer from B-12 deficiency
According to the Food and Drug Administration (FDA), animal studies suggest it can cause birth defects and an increased risk of pregnancy loss
Now, with Medicare and potentially Medicaid covering branded GLP-1s, the exclusivity that fueled $500-a-month subscriptions is evaporating
Exendin 939, a synthetic peptide derived from exendin-4 via N-terminal truncation and sharing 53% sequence homology with GLP-1, functions as a specific and competitive antagonist of GLP-1R [27]
US$ 27.97
US$ 20.25
US$ 29.79
US$ 27.33
